Efficacy of trastuzumab-based therapy after disease progression on lapatinib based therapy in heavily pretreated HER2-positive metastatic breast cancer patients.

Basit Öğe Kaydı
dc.contributor.authorUncu, Dogan
dc.contributor.authorBayoglu, Ibrahim Vedat
dc.contributor.authorArslan, Ulku Yalcintas
dc.contributor.authorKucukoner, Mehmet
dc.contributor.authorArtac, Mehmet
dc.contributor.authorKoca, Dogan
dc.contributor.authorOguz, Arzu
dc.date.accessioned2024-04-24T17:14:58Z
dc.date.available2024-04-24T17:14:58Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 30-JUN 03, 2014 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/jco.2014.32.15_suppl.e11586
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/jco.2014.32.15_suppl.e11586
dc.identifier.urihttps://hdl.handle.net/11468/18281
dc.identifier.volume32en_US
dc.identifier.wosWOS:000358613200080
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleEfficacy of trastuzumab-based therapy after disease progression on lapatinib based therapy in heavily pretreated HER2-positive metastatic breast cancer patients.en_US
dc.titleEfficacy of trastuzumab-based therapy after disease progression on lapatinib based therapy in heavily pretreated HER2-positive metastatic breast cancer patients.
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu